Full video transcriptClick to expand
Auto-generated transcript of @elevatemd's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00I have successfully lost 50 pounds after a pyramid of pause
- 0:03completely destroyed my metabolism.
- 0:05So I'm going to quickly run you through every single thing
- 0:07that I've done so that way you can do it too.
- 0:09Number one is HRT.
- 0:11There I say that this is the most important thing
- 0:13that is on this list.
- 0:14I'm on injectable aschodile, injectable testosterone,
- 0:17and then I take oral and suppository progesterone.
- 0:19These are my personal optimal ranges,
- 0:22but this is going to vary from person to person.
- 0:23Number two, I stopped eating in a deficit.
- 0:26I never eat below maintenance calories ever.
- 0:29I realized that my body really doesn't need
- 0:31the additional stress of thinking that it is starving.
- 0:33Number three, I stopped training super hard.
- 0:35I used to be a competitive bodybuilder,
- 0:37so making the switch to lower intensity training
- 0:39was actually really difficult for me,
- 0:41but I am now a long distance rollerblader
- 0:43and my body couldn't be happier.
- 0:45Number four, I have started recently microdosing a
- 0:48****** and this has made such a significant improvement
- 0:51for my inflammation.
- 0:52And last but not least, we have nervous system regulation.
- 0:55I have an abundance of videos on my page
- 0:57that explain different ways that you can help
- 0:58regulate your nervous system,
- 1:00but hands down, the most impactful thing
- 1:02that I've done for my nervous system is rest.
- 1:04I am no longer interested in running my body into the ground,
- 1:07so when my body wants to rest, I let my body rest
- 1:11without judgment.
- 1:12Let me know in the comments if you guys have
- 1:13any specific questions about any of this,
- 1:16or if you'd like me to dive deeper
- 1:17into any of these specific topics.
- 1:19You guys know I love talking about this stuff.
Perimenopause, testosterone, and weight loss: separating signal from noise
Quick answer
Testosterone therapy in perimenopausal women remains off-label in the United States, with the strongest evidence base limited to sexual function outcomes rather than weight loss or metabolic restoration. Estrogen decline during perimenopause does cause measurable shifts in fat distribution and insulin sensitivity, but these changes do not nullify the role of energy balance in weight management. Women considering hormone therapy should have baseline lab work including total and free testosterone, SHBG, estradiol, and a full metabolic panel before initiating any protocol.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 10 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Perimenopause, testosterone, and weight loss: separating signal from noise, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
Understanding weight gain at menopause
Background source for body-composition and weight-change discussions around menopause.
PubMed
Management of obesity in menopause
Current source for menopause-specific obesity management framing.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
Perimenopause, testosterone, and weight loss: separating signal from noise should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "Perimenopause, testosterone, and weight loss: separating signal from noise" from ElevateMD. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Testosterone therapy in perimenopausal women remains off-label in the United States, with the strongest evidence base limited to sexual function outcomes rather than weight loss or metabolic restoration.
The reason this review is not generic is the source wording and the canonical claim label "trt i have successfully lost 50lbs after perimenopause completel." In this clip, the useful excerpt is: "I have successfully lost 50 pounds after a pyramid of pause completely destroyed my metabolism." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
Testosterone therapy in perimenopausal women remains off-label in the United States, with the strongest evidence base limited to sexual function outcomes rather than weight loss or metabolic restoration.
FormBlends verdict
Testosterone evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Testosterone therapy in perimenopausal women remains off-label in the United States, with the strongest evidence base limited to sexual function outcomes rather than weight loss or metabolic restoration. Estrogen decline during perimenopause does cause measurable shifts in fat distribution and insulin sensitivity, but these changes do not nullify the role of energy balance in weight management. Women considering hormone therapy should have baseline lab work including total and free testosterone, SHBG, estradiol, and a full metabolic panel before initiating any protocol.
- Perimenopause causes real hormonal shifts that affect fat storage and insulin sensitivity, but total metabolic rate does not meaningfully collapse with age when lean mass is accounted for (Pontzer et al., 2021, Science).
- Testosterone therapy for women is off-label in the US, and the strongest published evidence supports its use for sexual function, not weight loss or metabolic optimization.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Perimenopause causes real hormonal shifts that affect fat storage and insulin sensitivity, but total metabolic rate does not meaningfully collapse with age when lean mass is accounted for (Pontzer et al., 2021, Science).
- Testosterone therapy for women is off-label in the US, and the strongest published evidence supports its use for sexual function, not weight loss or metabolic optimization.
- No peer-reviewed RCT has documented 50-pound weight loss from testosterone therapy alone in perimenopausal women without accompanying lifestyle changes.
- Testosterone pellet therapy in particular carries risks of supraphysiologic hormone levels, with androgenic side effects including acne, clitoral enlargement, and irreversible voice changes that are dose-dependent.
- The Endocrine Society recommends against testosterone use in women outside of specific clinical indications and advises physiologic dosing only when it is used.
- A 50-pound weight loss over any timeframe requires a full clinical workup and individualized protocol, not replication of another person's hormone regimen based on a social media video.
- Resistance training, sleep quality, and stress management have independent, well-documented effects on perimenopausal body composition and should not be discounted in favor of a purely hormonal explanation.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What's this video probably claiming?
Based on the caption and hashtag context, @elevatemd is almost certainly arguing that perimenopause tanked her metabolism through hormonal disruption, that conventional diet-and-exercise advice failed her, and that some form of hormone optimization, most likely testosterone therapy given the TRT category tag, helped her lose 50 pounds without simply eating less or training harder. The framing of "I did the complete opposite" is a classic social media setup for a hormone-as-magic-lever argument. Expect claims that declining testosterone (and possibly estrogen) caused fat accumulation, muscle loss, and metabolic slowdown, and that correcting those levels reversed the damage. This type of narrative is everywhere in the perimenopause wellness space right now, and it contains enough partial truth to be genuinely confusing to a lay audience.
What does the science actually show?
Perimenopause is a real metabolic event. Estrogen decline is associated with increased visceral adiposity, and several studies including Davis et al. (2012, Climacteric) documented measurable shifts in fat distribution during the menopausal transition independent of total caloric intake changes. Testosterone in women is trickier. A 2019 Cochrane review (Islam et al., Cochrane Database of Systematic Reviews) found testosterone therapy improved sexual function but evidence for body composition changes was limited and inconsistent across trials. A 12-week RCT by Huang et al. (2008, JAMA) showed testosterone supplementation in older women improved lean mass but did not produce significant weight loss on its own. The metabolic slowdown framing is also partially overstated: Pontzer et al. (2021, Science) showed total energy expenditure does not meaningfully decline between ages 20 and 60 when adjusted for lean mass, complicating the "destroyed metabolism" narrative considerably.
Where does the social media noise diverge from clinical reality?
The biggest divergence is the implication that hormone therapy replaces the need for caloric awareness. No peer-reviewed trial has shown testosterone therapy alone produces 50-pound weight loss in perimenopausal women without accompanying lifestyle changes. A 2022 systematic review by Glaser and Dimitrakakis (Maturitas) found testosterone pellet therapy in women produced modest improvements in body composition, not dramatic weight loss, and pellet dosing in particular carries significant risks of supraphysiologic levels. The "eat more, train less" framing is also almost certainly incomplete. More plausible is that she reduced inflammatory stress, improved sleep quality, or shifted training to resistance-focused work, all of which have independent evidence bases. Crediting hormones alone for a 50-pound loss, without disclosing the full behavioral picture, is where this content starts working against its audience.
What should you actually know?
If you're in perimenopause and struggling with weight, the honest picture is this: declining estrogen does shift fat toward visceral storage and can worsen insulin sensitivity, per Mauvais-Jarvis et al. (2013, Endocrine Reviews). Testosterone therapy for women remains off-label in the US and dosing protocols vary wildly, which matters because androgenic side effects including acne, hair thinning, and voice changes are dose-dependent. The Endocrine Society's 2014 guidelines (Wierman et al., Journal of Clinical Endocrinology and Metabolism) recommend against testosterone use in women outside of documented hypoactive sexual desire disorder, and even then, at doses designed to approximate normal female physiologic ranges. A 50-pound weight loss is a significant clinical outcome that warrants a serious conversation with a physician who can review your full hormonal panel, not a TikTok replication attempt.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
ElevateMD · TikTok creator
9.7K views on this video
I have successfully lost 50lbs after #perimenopause completely destroyed my metabolism, and I’m sharing every single thing I did so you can too. 🙌🏻 Let me be very clear about something first… I did NOT do this by eating less and training harder. In fact, I did the complete opposite, and THAT is what finally worked for me. Here’s exactly what changed: 🤌🏻 Hormone Therapy: Injectable estradiol, injectable Test osterone, & oral progesterone. Getting my hormones optimized was the foundation f
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about perimenopause causes real hormonal shifts?
Perimenopause causes real hormonal shifts that affect fat storage and insulin sensitivity, but total metabolic rate does not meaningfully collapse with age when lean mass is accounted for (Pontzer et al., 2021, Science).
What does the video say about testosterone therapy for women?
Testosterone therapy for women is off-label in the US, and the strongest published evidence supports its use for sexual function, not weight loss or metabolic optimization.
What does the video say about no peer-reviewed rct has documented 50-pound weight loss from testosterone?
No peer-reviewed RCT has documented 50-pound weight loss from testosterone therapy alone in perimenopausal women without accompanying lifestyle changes.
What does the video say about testosterone pellet therapy in particular carries risks of supraphysiologic hormone?
Testosterone pellet therapy in particular carries risks of supraphysiologic hormone levels, with androgenic side effects including acne, clitoral enlargement, and irreversible voice changes that are dose-dependent.
What does the video say about the endocrine society recommends against testosterone use in women outside?
The Endocrine Society recommends against testosterone use in women outside of specific clinical indications and advises physiologic dosing only when it is used.
What does the video say about a 50-pound weight loss over any timeframe requires a full?
A 50-pound weight loss over any timeframe requires a full clinical workup and individualized protocol, not replication of another person's hormone regimen based on a social media video.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by ElevateMD, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.